Cord blood myostatin concentrations by gestational diabetes mellitus and fetal sex

Bibliographic Details
Title: Cord blood myostatin concentrations by gestational diabetes mellitus and fetal sex
Authors: Rong Huang, Mark Kibschull, Laurent Briollais, Zdenka Pausova, Kellie Murphy, John Kingdom, Stephen Lye, Zhong-Cheng Luo
Source: Frontiers in Endocrinology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
Subject Terms: gestational diabetes mellitus, myostatin, testosterone, insulin-like growth factor, sex difference, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
More Details: IntroductionMyostatin is a member of the transforming growth factor β superfamily, and is mainly secreted from skeletal muscle. Animal studies have demonstrated that deficiency in myostatin promotes muscle growth and protects against insulin resistance. In humans, gestational diabetes mellitus (GDM) affects fetal insulin sensitivity. Females are more insulin resistant and weigh less than males at birth. We sought to assess whether cord blood myostatin concentrations vary by GDM and fetal sex, and the associations with fetal growth factors.MethodsIn a study of 44 GDM and 66 euglycemic mother-newborn dyads, myostatin, insulin, proinsulin, insulin-like growth factor (IGF)-1, IGF-2 and testosterone were measured in cord blood samples.ResultsCord blood myostatin concentrations were similar in GDM vs. euglycemic pregnancies (mean ± SD: 5.5 ± 1.4 vs. 5.8 ± 1.4 ng/mL, P=0.28), and were higher in males vs. females (6.1 ± 1.6 vs. 5.3 ± 1.0 ng/mL, P=0.006). Adjusting for gestational age, myostatin was negatively correlated with IGF-2 (r=-0.23, P=0.02), but not correlated with IGF-1 (P=0.60) or birth weight (P=0.23). Myostatin was strongly correlated with testosterone in males (r=0.56, P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-2392
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2023.1018779/full; https://doaj.org/toc/1664-2392
DOI: 10.3389/fendo.2023.1018779
Access URL: https://doaj.org/article/76552f1e1039474a83eacd2252c510f0
Accession Number: edsdoj.76552f1e1039474a83eacd2252c510f0
Database: Directory of Open Access Journals
More Details
ISSN:16642392
DOI:10.3389/fendo.2023.1018779
Published in:Frontiers in Endocrinology
Language:English